Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Tumor Response to Cancer Treatment Therapies

NCT02787954 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT02787954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02787954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Tumor Response to Cancer Treatment Therapies
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Observational
Overall status
Terminated
Start date
January 31, 2016
Completion date
April 30, 2017
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular cancer, metastatic liver cancer